版本:
中国

BRIEF-EU recommends approval of Novo Nordisk's haemophilia drug

March 24 EU Medicines Agency:

* EU Medicines Agency recommendations for March 2017

* Recommends approval of Novo Nordisk's Nonacog Beta Pegol drug for treatment of haemophilia

* Recommends approval of Pfizer's Trumenba drug for prophylaxis against invasive meningococcal disease Link to press release: (bit.ly/2nv0UIk) Further company coverage: (Bengaluru Newsroom: +91 806 749 1136)

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐